Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone

AIM: Few studies have examined abuse of prescription opioids (PO) among individuals with chronic pain under buprenorphine/naloxone (Bup/Nx) maintenance. The current 7-week inpatient study assessed oral oxycodone self-administration by patients with chronic pain who had a history of opioid abuse. MET...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Roux, Perrine, Sullivan, Maria A., Cohen, Julien, Fugon, Lionel, Jones, Jermaine D., Vosburg, Suzanne K., Cooper, Ziva D., Manubay, Jeanne M., Mogali, Shanthi, Comer, Sandra D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3770461/
https://ncbi.nlm.nih.gov/pubmed/23707283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pain.2013.05.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak